Table 2.
Cell | Curcumin Concentration/Duration | Effect | Reference |
---|---|---|---|
Hepatic stellate cells | 30 µM; 2 h | ↓ Cell proliferation ↑ Apoptosis ↓ α1(I) collagen, α-SMA and fibronectin mRNA ↑ p21 and p27 protein ↑ Caspase-3 activity ↓ Bcl-2 mRNA ↑ NF-κB activity |
[71] |
Primary mice isolated hepatocytes | 25 µM; 120 min | ↓ Hepatic glycogenolysis ↓ Hepatic gluconeogenesis ↓ G6Pase activity ↓ PEPCK activity ↑ Phospho-AMPK |
[72] |
H4IIE rat hepatoma and Hep3B human hepatoma cells | 2–50 µM; 30 min | ↓ Hepatic gluconeogenesis ↓ PEPCK activity ↓ G6Pase activity ↑ AMPK activation |
[73] |
Hepatic stellate cells | 0–30 µM; 1 h | ↓ HSC activation ↑ HSC apoptosis ↓ PDGF-βR and EGFR ↓ α-SMA and α-II-collagen ↑ PPARγ ↓ Bcl-2 ↑ Bax ↓ ROS levels ↑ GSH protein ↑ GSH/GSSG ratio ↑ GCL activity ↓ Phospho-InsR, -ERK1/2, -JNK, -PI3K and -Akt |
[74] |
Isolated rat hepatocytes | 1 and 10 µM; 30 min | 1 µM ↓ Lipid peroxidation ↓ Cytochrome c translocation 10 µM ↑ Oxidative stress ↑ Hepatocytoxicity ↑ Necrosis ↑ Apoptosis ↑ Glutathione depletion ↑ Caspase-3 activity |
[75] |
Rat HSCs and immortalized human hepatocytes | 20 µM; 1 h | ↓ Glucose levels ↓ GLUT4 membrane translocation ↑ Glucokinase activity ↑ Glucose-6-phosphate levels ↓ Phospho-IRS-1 ↓ Phospho-PI3K ↓ Phospho-Akt |
[76] |
Huh7 cells | 20 µM; 48 h | ↑ PON1 transactivation ↑ PON1 mRNA and protein |
[77] |
L02 hepatocytes | - | ↓ Oxidative stress ↓ Insulin resistance ↓ ROS production ↓ Glutathione depletion ↓ MDA levels ↓ LDH activity ↓ AST activity |
[78] |
Primary rat hepatocytes | 10 µM; 12 h | ↓ Lipo-apoptosis ↓ ROS production ↓ ATP depletion ↓ PEPCK levels ↓ G6Pase levels ↑ Mitochondrial DNA ↑ PGC1α, NRF1 and Tfam mRNA ↑ MMP ↓ NF-kB p65 mRNA |
[79] |
AML-12 cells | 50 µM; 2 h | ↑ Insulin response ↑ Phospho-PKB ↓ ROS levels ↓ MDA levels ↓ Phospho-JNK ↓ Phospho-p38 |
[80] |
Primary rat hepatocytes | 15 µM; 24 h | ↓ Lipid formation ↑ APOBEC-1 mRNA and protein ↑ ApoB mRNA editing ↓ Apo-B lipid formation |
[81] |
HepG2 cells | 30 µM; 2 h | ↓ Cholesterol cell content ↓ Endosome/lysosome size and localization ↑ Cholesterol β-hexosaminidase enzyme level ↑ Lysosomal β-hexosaminidase enzyme level ↑ Flotillin-2-positive granules ↑ CD63-positive granules |
[82] |
HepG2 cells | 5–20 µM; 24 h | ↑ Hypolipidemic activity ↑ LDL uptake ↑ LDL receptor expression ↑ LDL receptor activity ↓ PCSK9 mRNA and protein ↓ PCSK9 promoter activity ↓ HNF-1α mRNA and protein ↓ HNF-1α nuclear promoter |
[83] |
L02 cells | 2.5 and 5 µM; 2 h | ↓ Oxidative stress ↑ Cell viability ↓ DNA-fragments ↓ Micronuclei formation ↓ ROS production ↑ SOD activity ↑ GSH levels |
[84] |
Primary mice hepatocytes | 25 µM; 6 h | ↓ Glucose production ↑ FGF21 protein ↑ Phospho-Akt |
[85] |
L02 cells | 5 µM; 2 h | ↓ QCT-induced inflammatory response ↓ QCT-induced oxidative stress ↓ Mitochondrial dysfunction ↓ Apoptosis ↓ iNOS activity ↓ NO production ↓ NF-κB mRNA ↑ Nrf2 and HO-1 mRNA |
[86] |
HepG2 cells | 30 µM; 24 h | ↓ Hepatic steatosis ↑ Leptin resistance ↓ Lipid deposition ↓ SREBP-1c, SCD-1 and CD36 mRNA ↑ ACC, ACOX1, CPT-1 and PPARα mRNA ↑ Phospho-AMPK ↑ Phospho-ACC |
[87] |
Primary mouse hepatocytes | 1 µM; 4 h | ↑ Lipogenesis ↑ ChREBP activation ↑ ChREBP mRNA ↑ Lpk, Fas, Acc1, Scd1 and Me1 mRNA ↑ ChREBP-LUC activity ↓ Oct-1-ChREBP binding |
[88] |
HepG2 and primary mouse hepatocytes | 2 µM; 6 h | ↓ Fgf21 resistance ↑ Fgf21 activity ↑ Fgf21 mRNA ↑ PPARα mRNA ↑ Fgf21-LUC activity ↑ PPARα-Fgf21 binding |
[89] |
HepG2 cells | 5 µM; 5 days | ↓ Insulin resistance ↑ Glucose consumption ↓ Oxidative stress ↑ Phospho-IR ↑ Phospho-Akt ↓ MDA levels ↓ IL-6 levels ↓ TNF-α levels ↓ Phospho-JNK and p38 ↓ Phospho-IKKβ and IκB-α |
[90] |
Human LX-2 HSCs | 40 µM; 24 h | ↓ Fibrotic myofibroblastic phenotype ↑ Lipocyte phenotype ↑ Lipid droplet abundance ↑ Lipid metabolism ↑ Triglyceride content ↑ Nrf2 protein and nuclear translocation ↑ C/EBPα, PPARγ, RXRα and RXRβ protein ↓ PPARα protein |
[91] |
Primary mice hepatocytes | 10 µM; 24 h | ↓ Palmitate-induced steatosis ↑ CYP7A and CYP3A protein ↓ SREBP-1c protein |
[92] |
HepG2 cells and primary mice hepatocytes | 10 µM; 30 and 120 min | ↓ Glucose production ↓ Mitochondrial complex I activity ↓ cAMP accumulation ↑ PDE4B induction ↑ Phospho-AMPK ↓ Acetyl CoA accumulation ↓ PDK4 mRNA ↓ PDH activity ↓ PC protein |
[93] |
BRL-3A and HepG2 cells | 2.5 µM; 8 and 12 h | ↓ Fructose-induced inflammation ↓ NLRP3 inflammasome activity ↑ miR-200a level ↓ NLRP3 and ASC protein ↓ Caspase-1 and IL-1β protein ↓ TXNIP protein ↓ ROS production ↓ H2O2 levels |
[94] |
HepG2 cells | 10 µM; 24 h | ↓ Lipotoxicity ↓ Lipid vacuole accumulation ↓ ROS production ↓ SREBP-1, PPAR-γ2 and PARP levels ↓ Cleaved caspase 3 levels |
[95] |
HepG2 cells | 10 µM; 1 h | ↓ Palmitate-induced inflammatory injury ↓ Palmitate-induced fibrosis ↓ TNF-α, IL-6, IL-1β and COX-2 mRNA ↓ ICAM, VCAM-1 and MCP-1 mRNA↓ α-SMA, COL-1, COL-4 and TGF-β mRNA ↓ α-SMA protein |
[96] |